Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years

MLA

Gianluca Vita, et al. “Long-Term Treatment with Subcutaneous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Follow-up Period up to 7 Years.” Scientific Reports, vol. 10, no. 1, May 2020, pp. 1–5. EBSCOhost, https://doi.org/10.1038/s41598-020-64699-6.

APA

Gianluca Vita, Luca Gentile, Anna Mazzeo, Antonio Toscano, Margherita Russo, & Ilenia Arimatea. (2020). Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years. Scientific Reports, 10(1), 1–5. https://doi.org/10.1038/s41598-020-64699-6

Chicago

Gianluca Vita, Luca Gentile, Anna Mazzeo, Antonio Toscano, Margherita Russo, and Ilenia Arimatea. 2020. “Long-Term Treatment with Subcutaneous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Follow-up Period up to 7 Years.” Scientific Reports 10 (1): 1–5. doi:10.1038/s41598-020-64699-6.